المؤلفون: Rumiantseva IuV, Karachunskiĭ AI, Aleĭnikova OV, Fechina LG, Shamardina AV, Litvinov DV, Ponomareva NI, Boĭchenko EG, Dudkin SA, Streneva OV, Kondratchik KL, Mansurova EG, Minkina LM, Lapotentova ES, Iniushkina EV, Iudina NB, Pavlova GP, Zhukovskaia EV, Khlebnikova OP, Lagoĭko SN, Basharova EV, Denisov RE, Zlobina VD, Banshchikova ES, Aslanian KS, Kondakova EV, Tselousova EV, Miakova NV, Turobova TV, Ryskal' OV, Chipsanova NF, Varfolomeeva SR, Rumiantsev AG

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2010; Vol. 82 (7), pp. 11-9.

نوع المنشور: Clinical Trial; English Abstract; Journal Article; Multicenter Study

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Age Factors ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Child ; Child, Preschool ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Infant ; Male ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/prevention & control ; Recurrence ; Russia